LiDCO Group plc : Launch of the LiDCOrapid monitor in Japan

LiDCO Group Plc (AIM:LID), the UK-based hemodynamic monitoring company, announces the formal launch in Japan of the LiDCOrapidmonitor at the59th Annual Meeting of the Japanese Society of Anesthesiologists in Kobe (7-9 June).  

Dr David Green of King's College Hospital, London spoke at the meeting about his wide experience managing high-risk surgery patients with LiDCO's technology. His talk, entitled:"Optimal fluid, depth of anesthesia and hemodynamic management of the high risk surgery patient", was enthusiastically received with over 400 anesthetists attending the seminar chaired by Professor Kiyoshi Morita, President Okayama University.

Dr Terry O'Brien, CEO of LiDCO, commented: "We recently announcedthat the LiDCOrapidMonitor, and associated disposable products, were successfully approved by the Japanese Ministry of Health, Labour and Welfare (MHLW). This registration was very timely, allowing our partner Argon, to launch the monitor to Japanese anesthesiologists attending their annual scientific meeting. Japan is the second largest market in the world for our products.

"Dr Green's presentation highlighted how LiDCOrapidcan optimally manage patient's fluids status during surgery. He also gave an in-depth insight into the improved clinical utility that monitor parameter convergence could bring, in particular LiDCO's plans for adding depth of anesthesia and non-invasive blood pressure to the LiDCOrapidlater in this year."

- Ends -

For further information, please contact:

Media enquiries:

About LiDCO Group Plc

LiDCO is a supplier of minimally invasive hemodynamic monitoring equipment and disposables to hospitals. These products are used primarily for the management of adult hospital patients requiring critical care or at major cardiovascular risk. LiDCO's computer-based technology can significantly reduce the complications (particularly infections) and costs associated with major surgery. The technology was invented in the Department of Applied Physiology based at St Thomas' Hospital, London. LiDCO is based in the UK and its shares are traded on AIM. For more information please seewww.lidco.com.

The Company's sales office is in Cambridge, its manufacturing facility / general administration base is in Hoxton, London, and its current products are:

* LiDCOplusis a computer-based platform monitor used in the Intensive Care Unit for real-time continuous display of hemodynamic parameters including cardiac output, oxygen delivery and fluid-volume responsiveness (PPV% and SVV%)

* LiDCOrapid:our new cardiac output monitor designed specifically for use in the Operating Theatre for fluid and drug management.The monitor enables acute-care physicians to get accurate and immediate feedback on the patient's fluid and hemodynamic status - a key measure of overall well-being both during and after surgery.  These benefits are:

* LiDCO single-patient-use disposablesused in conjunction with the LiDCOplusand LiDCOrapid.

*LiDCOview: an easy-to-use graphical display of historical LiDCOplusand LiDCOrapidhemodynamic data.

*  LiDCO's Distribution Network:

The Company sells via its own direct sales force to hospitals in the UK, and in export markets predominantly through a worldwide network of speciality critical care and anesthesia distributors.